Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Estradiol Dose on Symptom Provocation in PMDD
2004-004516-22Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Nov 2004
- Countries
- 1
01
Overview
Phase 4 trial of estradiol in Premenstrual Dysphoric Disorder (PMDD) (2 arms), sponsored by Uppsala University. Primary endpoint: Daily Cyclicity Diagnoser scores in the last 14 days of each treatment cycle. Started Nov 2004; status: completed.
02
Drugs
estradiol
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on 2004-004516-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004516-22.